A Study of Rituximab in Combination With Fludarabine and Cyclophosphamide in Participants With Chronic Lymphocytic Leukemia and Favorable Somatic Status
Clinical trial NCT01271010 · TERMINATED
Trial details
- NCT number
- NCT01271010
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-17
- Primary completion
- 2016-05-04
- Enrollment
- 89
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.